Prebiotic and probiotic fortified milk in prevention of morbidities among children: Community-based, randomized, double-blind, controlled trial

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Sazawal, Sunil ^a,b   Dhingra, Usha ^a   Hiremath, Girish ^a   Sarkar, Archana ^b   Dhingra, Pratibha ^b   Dutta, Arup ^a   Verma, Priti ^b   Menon, Venugopal P ^b   Black, Robert E ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b ANNAMALAI UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BIFIDOBACTERIUM LACTIS EXTRACT; PREBIOTIC AGENT; PROBIOTIC AGENT; UNCLASSIFIED DRUG; OLIGOSACCHARIDE;

AGE DISTRIBUTION; ARTICLE; ARTIFICIAL MILK; CHILD; CHILD HEALTH; CLINICAL TRIAL; COMMUNITY CARE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SURVEILLANCE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSENTERY; FEVER; FOLLOW UP; HUMAN; INCIDENCE; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MORBIDITY; PATIENT COMPLIANCE; PNEUMONIA; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; RISK REDUCTION; ANIMAL; BIFIDOBACTERIUM; DIET SUPPLEMENTATION; INFANT; MICROBIOLOGY; MILK; PHYSIOLOGY; TIME; URBAN POPULATION;

BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS;

ANIMALS; BIFIDOBACTERIUM; CHILD, PRESCHOOL; DIARRHEA; DOUBLE-BLIND METHOD; FOOD, FORTIFIED; HUMANS; INFANT; MILK; MORBIDITY; OLIGOSACCHARIDES; PREBIOTICS; PROBIOTICS; RESPIRATORY TRACT INFECTIONS; TIME; URBAN POPULATION;

EID: 77957887347     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012164     Document Type: Article

References (46)

1. Bryce J, Boschi-Pinto C, Shibuya K, Black RE (2005) WHO Child Health Epidemiology Reference Group. WHO estimates of the causes of death in children. Lancet 365: 1147-1152.
2. Black RE, Allen LH, Bhutta ZA, Caulfield LE, de OM, et al. (2008) Maternal and child undernutrition: global and regional exposures and health consequences. Lancet 371: 243-260.
3. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367: 1747-1757.
4. United Nations, General Assembly, 56th session (2001) Road map toward the implementation of the United Nations millennium declaration: report of the Secretary General (UN document no. A/56/326). New York: United Nations.
5. Bryce J, Black RE, Walker N, Bhutta ZA, Lawn JE, et al. (2005) Can the world afford to save the lives of 6 million children each year? Lancet 365: 2193-2200.
6. Rudan I, Lawn J, Cousens S, Rowe AK, Boschi-Pinto C, et al. (2005) Gaps in policy-relevant information on burden of disease in children: a systematic review. Lancet 365: 2031-2040.
7. Szajewska H, Mrukowicz JZ (2005) Use of probiotics in children with acute diarrhea. Paediatr Drugs 7: 111-122.
8. Roberfroid MB (2001) Prebiotics: preferential substrates for specific germs? Am J Clin Nutr 73: 406S-409S.
9. Van Niel CW, Feudtner C, Garrison MM, Christakis DA (2002) Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 109: 678-684.
10. Canani RB, Cirillo P, Terrin G, Cesarano L, Spagnuolo MI, et al. (2007) Probiotics for treatment of acute diarrhoea in children: randomized clinical trial of five different preparations. BMJ 335: 340.
11. Szajewska H, Skórka A, Dylag M (2007) Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children. Aliment Pharmacol Ther 25: 257-264.
12. Huang JS, Bousvaros A, Lee JW, Diaz A, Davidson EJ (2002) Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci 47: 2625-2634.
13. Basu S, Chatterjee M, Ganguly S, Chandra PK (2007) Effect of Lactobacillus rhamnosus GG in persistent diarrhea in Indian children: a randomized controlled trial. J Clin Gastroenterol 41: 756-760.
14. Szajewska H, Ruszczyński M, Radzikowski A (2006) Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J Pediatr. 149: 367-372.
15. Rohde CL, Bartolini V, Jones N (2009) The use of probiotics in the prevention and treatment of antibiotic-associated diarrhea with special interest in Clostridium difficile-associated diarrhea. Nutr Clin Pract 24: 33-40.
16. Hickson M, D'Souza AL, Muthu N, Rogers TR, Want S, Rajkumar C, Bulpitt CJ (2007) Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomized double blind placebo controlled trial. BMJ 335: 80.
17. Reid G, Jass J, Sebulsky MT, McCormick JK (2003) Potential uses of probiotics in clinical practice. Clin Microbiol Rev 16: 658-672.
18. Binns CW, Lee AH, Harding H, Gracey M, Barclay DV (2007) The CUPDAY Study: prebiotic-probiotic milk product in 1-3-year-old children attending childcare centres. Acta Paediatr 96: 1646-1650.
19. Mateos JA, Muñoz Conejo A (2006) Effect of Lactobacillus casei on the incidence of infectious conditions in children. Nutr Hosp 21: 547-551.
20. Hatakka K, Savilahti E, Pönkä A, Meurman JH, Poussa T, et al. (2001) Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomized trial. BMJ 322: 1327.
21. Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S, et al. (2006) Efficacy of probiotics in prevention of acute diarrhea: a meta-analysis of masked, randomized, placebo-controlled trials. Lancet Infect Dis 6: 374-382.
22. Szajewska H, Mrukowicz JZ (2001) Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr 33: S17-S25.
23. Oberhelman RA, Gilman RH, Sheen P, Taylor DN, Black RE, et al. (1999) A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J Pediatr 134: 15-20.
24. Sazawal S, Dhingra U, Dhingra P, Hiremath G, Sarkar A, et al. (2010) Micronutrient fortified milk improves iron status, anemia and growth among children 1-4 years: A double masked, randomized, controlled trial. PLoS ONE 5(8): e12167. doi:10.1371/journal.pone.0012167.
25. Sazawal S, Dhingra U, Dhingra P, Hiremath G, Kumar J, et al. (2007) Effects of fortified milk on morbidity in young children in north India: community based, randomised, double masked placebo controlled trial. BMJ 334: 140.
26. Sazawal S, Black RE, Jalla S, Mazumdar S, Sinha A, et al. (1998) Zinc supplementation reduces the incidence of acute lower respiratory infections in infants and preschool children: a double-blind, controlled trial. Pediatrics 102: 1-5.
27. WHO Multicentre Growth Reference Study Group (2006) WHO Child Growth Standards: Length/height-for-age, weight-for-age, weight-for-length, weight-forheight and body mass index-for-age: Methods and development. Geneva: World Health Organization. pp 312. (Accessed May 9, 2009 at http://www.who.int/childgrowth/publications/en).
28. Gill HS, Rutherfurd KJ, Prasad J, Gopal PK (2000) Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br J Nutr 83: 167-176.
29. Shu Q, Qu F, Gill HS (2001) Probiotic treatment using Bifidobacterium lactis HN019 reduces weanling diarrhea associated with rotavirus and Escherichia coli infection in a piglet model. J Pediatr Gastroenterol Nutr 33: 171-177.
30. Shu Q, Gill HS (2001) A dietary probiotic (Bifidobacterium lactis HN019) reduces the severity of Escherichia coli O157:H7 infection in mice. Med Microbiol Immunol (Berl) 189: 147-152.
31. Arunachalam K, Gill HS, Chandra RK (2000) Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). Eur J Clin Nutr 54: 263-267.
32. Chiang BL, Sheih YH, Wang LH, Liao CK, Gill HS (2000) Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Bifidobacterium lactis HN019): optimization and definition of cellular immune responses. Eur J Clin Nutr 54: 849-855.
33. Gill HS, Rutherfurd KJ, Cross ML, Gopal PK (2001) Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr 74: 833-839.
34. McNabb B, Isakow W (2008) Probiotics for the prevention of nosocomial pneumonia: current evidence and opinions. Curr Opin Pulm Med 14: 168-175.
35. Mastretta E, Longo P, Laccisaglia A, Balbo L, Russo R, et al. (2002) Effect of Lactobacillus GG and breast-feeding in the prevention of rotavirus nosocomial infection. J Pediatr Gastroenterol Nutr 35: 527-531.
36. Honeycutt TC, El Khashab M, Wardrop RM, 3rd, McNeal-Trice K, Honeycutt AL, et al. (2007) Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: a randomized placebocontrolled trial. Pediatr Crit Care Med 8: 452-458.
37. Chouraqui JP, Van Egroo LD, Fichot MC (2004) Acidified milk formula supplemented with bifidobacterium lactis: impact on infant diarrhea inresidential care settings. J Pediatr Gastroenterol Nutr 38: 288-292.
38. Thibault H, Aubert-Jacquin C, Goulet O (2004) Effects of long-term consumption of a fermented infant formula (with Bifidobacterium breve c50 and Streptococcus thermophilus 065) on acute diarrhea in healthy infants. J Pediatr Gastroenterol Nutr 39: 147-152.
39. Saavedra JM, Abi-Hanna A, Moore N, Yolken RH (2004) Long-term consumption of infant formulas containing live probiotic bacteria: tolerance and safety. Am J Clin Nutr 79: 261-267.
40. Weizman Z, Asli G, Alsheikh A (2005) Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 115: 5-9.
41. Guandalini S (2008) Probiotics for children with diarrhea: an update. J Clin Gastroenterol 42: S53-S37.
42. Bhan MK, Bhandari N, Sazawal S, Clemens J, Raj P (1989) Descriptive epidemiology of persistent diarrhoea among young children in rural northern India. Bull World Health Organ 67: 281-288.
43. Contreras G, Corti C, Cassani (1983) [Lactobacillus acidophilus in childhood diarrhea]. Compend Invest Clin Latinoam 3: 114-116.
44. Coconnier MH, Lievin V, Bernet-Camard MF, Hudault S, Servin AL (1997) Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB. Antimicrob Agents Chemother 41: 1046-1052.
45. Axelson LT, Chung TC, Dobrogosz WJ, Lindgren SE (1989) Production of a broad spectrum antimicrobial substance by Lactobacillus reuteri. Microb Ecol Health Dis 8: 131-136.
46. Selva M, Jacobus NV, Deneke C, Gorbach SL (1987) Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother 31: 1231-1233.